======= INTS3 ======= == Gene Information == * **Official Symbol**: INTS3 * **Official Name**: integrator complex subunit 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=65123|65123]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q68E01|Q68E01]] * **Interactions**: [[https://thebiogrid.org/search.php?search=INTS3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20INTS3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611347|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene can form a complex with human single-strand DNA binding proteins 1 or 2 (hSSB1 and hSSB2) and other proteins to mediate genome stability and the DNA damage response. The encoded protein is also part of a multiprotein complex that interacts with the C-terminal domain of RNA polymerase II large subunit to help regulate processing of U1 and U2 small nuclear RNAs. [provided by RefSeq, May 2016]. * **UniProt Summary**: N/A |DUF2356| |SOSS complex| |integrator complex| |snRNA processing| |snRNA metabolic process| |snRNA transcription by RNA polymerase II| |snRNA transcription| |ncRNA transcription| |response to ionizing radiation| |mitotic cell cycle checkpoint| |cell cycle checkpoint| |negative regulation of mitotic cell cycle| |ncRNA processing| |response to radiation| |ncRNA metabolic process| |transcription by RNA polymerase II| |DNA repair| |negative regulation of cell cycle| |mitotic cell cycle process| |regulation of mitotic cell cycle| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |mitotic cell cycle| |DNA metabolic process| |cellular response to DNA damage stimulus| |nucleolus| |RNA processing| |cell cycle process| |nucleobase-containing compound biosynthetic process| |response to abiotic stimulus| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |organic cyclic compound biosynthetic process| |cell cycle| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular response to stress| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|-2.63| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|-2.52| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|-2.38| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-2.23| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.22| |[[:results:exp380|NMS-873 0.07μM R07 exp380]]|-2.18| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|-2.18| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|-2.15| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-2.1| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-2.09| |[[:results:exp423|Zebularine 20μM R07 exp423]]|-2.02| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-1.98| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|-1.96| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-1.91| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-1.89| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-1.89| |[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|-1.85| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-1.82| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|-1.81| |[[:results:exp360|Genistein 15μM R07 exp360]]|-1.78| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|-1.77| |[[:results:exp393|Resminostat 0.5μM R07 exp393]]|-1.73| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|-1.71| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|-1.7| |[[:results:exp133|MKC9989 10μM R03 exp133]]|1.91| |[[:results:exp4|Actinomycin-D 0.01μM R00 exp4]]|1.97| |[[:results:exp7|Bortezomib 0.05μM R00 exp7]]|2.1| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.433| Global Fraction of Cell Lines Where Essential: 733/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|26/26| |breast|31/33| |central nervous system|56/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|21/21| |liver|20/20| |lung|74/75| |lymphocyte|16/16| |ovary|25/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|9/9| |thyroid|2/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 144 * **Expression level (log2 read counts)**: 6.57 {{:chemogenomics:nalm6 dist.png?nolink |}}